Natal-V RX Tablets by Rochester Pharmaceuticals — Ingredients, Evidence & Safety

🟢 100/100

This product looks safe

No ingredients exceed tolerable upper intake levels
72% of ingredients have research evidence

A Label Compliance Grade

Product Label

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Tablet(s) Serving Size

90 Servings

Multi-Vitamin and Mineral (MVM) Product Type

72% Evidence Coverage

Supplement Facts — Evidence Check

Vitamin A

4000 IU (50% DV)

Vitamin C

120 mg (200% DV)

Vitamin D3

400 IU (100% DV)

✅ Within RDA (0.7× RDA of 0.015 mg) 📚 604 studies (Tier A: 16, B: 251)

RDA 0.015mg This product: 0.01mg UL 0.1mg

Vitamin E

30 IU (100% DV)

✅ 1.3× RDA — within safe limits 📚 177 studies (Tier A: 3, B: 90)

RDA 15mg This product: 20.1mg UL 1000mg

Vitamin B1

3 mg (176% DV)

✅ 2.5× RDA — within safe limits 📚 76 studies (Tier A: 0, B: 33)

RDA 1.2mg This product: 3mg

Vitamin B2

3 mg (150% DV)

✅ 2.3× RDA — within safe limits 📚 12 studies (Tier A: 0, B: 1)

RDA 1.3mg This product: 3mg

Niacinamide

20 mg (100% DV)

✅ 1.4× RDA — within safe limits 📚 193 studies (Tier A: 5, B: 63)

RDA 14mg This product: 20mg UL 35mg

Vitamin B6

3 mg (120% DV)

✅ 2.3× RDA — within safe limits 📚 113 studies (Tier A: 3, B: 35)

RDA 1.3mg This product: 3mg UL 100mg

Folic Acid

1 mg (125% DV)

✅ 2.5× RDA — within safe limits 📚 225 studies (Tier A: 10, B: 105)

RDA 0.4mg This product: 1mg UL 1.0mg

Vitamin B12

8 mcg (100% DV)

📊 3.3× RDA — above typical dose 📚 138 studies (Tier A: 1, B: 44)

RDA 0.0024mg This product: 0.008mg

Biotin

30 mcg (10% DV)

✅ Within RDA (1.0× RDA of 0.03 mg) 📚 26 studies (Tier A: 0, B: 11)

RDA 0.03mg This product: 0.03mg

Pantothenic Acid

7 mg (70% DV)

✅ 1.4× RDA — within safe limits 📚 1 studies — no high-quality reviews

RDA 5mg This product: 7mg

Calcium

200 mg (15% DV)

Iron

29 mg (161% DV)

Iodine

150 mcg (100% DV)

✅ Within RDA (1.0× RDA of 0.15 mg) 📚 243 studies (Tier A: 4, B: 133)

RDA 0.15mg This product: 0.15mg UL 1.1mg

Magnesium

100 mg (22% DV)

📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)

This product: 100mg

Zinc

15 mg (100% DV)

✅ 1.4× RDA — within safe limits 📚 258 studies (Tier A: 6, B: 134)

RDA 11mg This product: 15mg UL 40mg

Copper

3 mg (150% DV)

📊 3.3× RDA — above typical dose (UL: 10 mg) 📚 36 studies (Tier A: 0, B: 11)

RDA 0.9mg This product: 3mg UL 10mg

Other Ingredients

Microcrystalline Cellulose Starcap 1500 Polyethylene Glycol Polyvinyl Alcohol Titanium Dioxide Talc FD&C Blue #1 FD&C Red #40 FD&C Yellow #6 Colloidal Silicon Dioxide Magnesium Stearate

Label Claims — Verification

❓ Nutrient

❓ All Other

❓ Structure/Function

All Other (99% of products) Structure/Function (76% of products) Nutrient (58% of products)

Target Groups

Pregnant Women Adult Female (18 - 50 Years) Lactating

Product Information

📋 Directions for Use

Directions: One tablet daily or as directed by a physician. Each tablet is pink colored, oval-shaped, and embossed with "RP204" on one side.

⚠️ Warnings & Precautions

Contraindications: This product is contraindicated in patients with a known hypersensitivity to any of the components of this product.

Warnings: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of the reach of children. In case of accidental overdose, call a doctor or Poison Control Center immediately.

Caution: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megalobastic anemias where Vitamin B-12 is deficient.

Precautions: Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive. Pernicious anemia should be excluded before using this product since folic acid may mask the symptoms of pernicious anemia.

Adverse Reactions: Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

Keep out of reach of children.

Do not use if imprinted safety seal under cap is broken or missing.

Hemochromatosis and Hemosiderosis are contraindications to iron therapy.

To report a serious adverse event or to obtain product information, contact 1-866-458-1772.

🧪 Formulation Notes

Multi-vitamin/Multi-mineral

Indications: To provide vitamin and mineral supplementation throughout pregnancy and during the postnatal period for both the lactating and nonlactating mother.

Additional Information

Storage: Store at 20 degrees C to 25 degrees C (68 degrees F to 77 degrees F), excursions permitted between 15 degrees C and 30 degrees C (between 59 degrees F and 86 degrees F).

NDC 49908-204-90 Rx only

Product Details

UPC / SKU 3 49908 20490 6

DSLD Entry Date 2022-01-22

Product Type Multi-Vitamin and Mineral (MVM)

Form Tablet or Pill

Brand Rochester Pharmaceuticals

DSLD ID 263909

Data Updated 2026-04-11

Research Evidence

337 Research Sources

54 Avg Quality Score

161 Meta Analysis

68 Systematic Review

51 Rct

48 Clinical Trial

2 Other

2 Regulatory Source

1 Narrative Review

1 Cochrane Review

1 Guideline

1 Openfda Safety

A Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age

Meta Analysis The Cochrane database of systematic reviews 2017

PubMed DOI Cochrane

A Vitamin A supplementation for the prevention of morbidity and mortality in infants six months of age or less

Meta Analysis The Cochrane database of systematic reviews 2011

PubMed DOI Cochrane

A Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection

Meta Analysis The Cochrane database of systematic reviews 2011

PubMed DOI Cochrane

A Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis

Meta Analysis BMJ (Clinical research ed.) 2011

PubMed DOI

A Fortification of staple foods with vitamin A for vitamin A deficiency

Systematic Review The Cochrane database of systematic reviews 2019

PubMed DOI Cochrane

A Vitamin A supplementation for the prevention of morbidity and mortality in infants one to six months of age

Narrative Review The Cochrane database of systematic reviews 2016

PubMed DOI Cochrane

A Vitamin A and fish oils for preventing the progression of retinitis pigmentosa

Meta Analysis The Cochrane database of systematic reviews 2020

PubMed DOI

A Exercise training-induced changes in exerkine concentrations may be relevant to the metabolic control of type 2 diabetes mellitus patients: A systematic review and meta-analysis of randomized controlled trials

Meta Analysis Journal of sport and health science 2023

PubMed DOI

A Food fortification with multiple micronutrients: impact on health outcomes in general population

Meta Analysis The Cochrane database of systematic reviews 2019

PubMed DOI

A Oral vitamin A supplements to prevent acute upper respiratory tract infections in children up to seven years of age

Meta Analysis The Cochrane database of systematic reviews 2024

PubMed DOI

View all evidence for Vitamin A →